Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics

BMC Public Health

Table 3 Multivariate models of effects of intervention and process measures on HPV vaccination outcomes

	Receipt of HPV vaccine dose at initial visit		Completion of 3 doses at 12-month follow up
	Adjusted RR^b	(95% CI)^c	Adjusted RR^b	(95% CI)^c
Intervention (usual care-reference)	0.86	(0.61-1.21)	0.48	(0.25-0.92)
Patient education materials provided^a	1.13	(0.76-1.68)	0.93	(0.49-1.78)
Provider recommended vaccine	4.08	(2.17-7.66)	1.44	(0.68-3.05)
Mother’s educational level	0.92	(0.78-1.08)	0.82	(0.61-1.09)
Child’s age	1.07	(1.02-1.12)	1.19	(1.09-1.30)

^aPatient Education Materials included the intervention video and/or card in the intervention arm, or any printed materials about HPV vaccine in the usual care arm
^b RR relative risk adjusted for other variables in the model
^c CI confidence interval

ISSN: 1471-2458